Seascape Capital Management Bristol Myers Squibb CO Transaction History

Seascape Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	SELL	$63.71 - $70.74 $5,733 - $6,366	-90 Reduced 2.75%	3,178 $203,000
Q1 2023 May 01, 2023	BUY	$65.71 - $74.53 $4,533 - $5,142	69 Added 2.16%	3,268 $227,000
Q4 2022 Jan 31, 2023	SELL	$68.48 - $81.09 $50,949 - $60,330	-744 Reduced 18.87%	3,199 $230,000
Q3 2022 Nov 08, 2022	BUY	$0.13 - $76.84 $104 - $61,856	805 Added 25.65%	3,943 $280,000
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $227,881 - $250,977	3,138 New	3,138 $242,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Seascape Capital Management, based on Form 13F filings with the SEC.

Stay updated on Seascape Capital Management with notifications on news.